Compensations after lesions of central dopaminergic neurons: some clinical and basic implications.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Trends in Neurosciences

• Publication date

  1990-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0166-2236(90)90112-NPMID 1695406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.

  1990cited by this paper
• Differential Effect of Stress on In Vivo Dopamine Release in Striatum, Nucleus Accumbens, and Medial Frontal Cortex

  1989cited by this paper
• Dopaminergic inhibition of striatal acetylcholine release after 6-hydroxydopamine.

  1989cited by this paper
• Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage.

  1988cited by this paper
• Presynaptic regulation of dopaminergic transmission in the striatum

  1988cited by this paper
• MPTP toxicity: implications for research in Parkinson's disease.

  1988cited by this paper
• Evidence for two functionally distinct subpopulations of neurons within the rat striatum

  1988cited by this paper
• Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.

  1988cited by this paper
• Increased dopamine efflux from striatal slices during development and after nigrostriatal bundle damage

  1987cited by this paper
• Short-term effects of dopamine-depleting brain lesions on spontaneous activity of striatal neurons: relation to local dopamine concentration and behavior.

  1986cited by this paper
• Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery.

  1986cited by this paper
• Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum.

  1986cited by this paper
• Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum.

  1985cited by this paper
• Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis.

  1984cited by this paper
• Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism.

  1984cited by this paper
• The control of firing pattern in nigral dopamine neurons: burst firing

  1984cited by this paper
• The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

  1983cited by this paper
• Dopamine receptor changes following destruction of the nigrostriatal pathway: lack of a relationship to rotational behavior.

  1981cited by this paper
• Supersensitivity after intraventricular 6-hydroxydopamine: Relation to dopamine depletion

  1980cited by this paper
• Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization.

  1980cited by this paper
• Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.

  1979cited by this paper
• Effects of l-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices.

  1978cited by this paper
• Short-Term increase and long-term reversion of striatal cell activity after degeneration of the nigrostriatal dopamine system

  1978cited by this paper
• Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.

  1977cited by this paper
• Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.

  1975cited by this paper
• 6-Hydroxydopamine and striatal acetylcholine levels.

  1974cited by this paper
• Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.

  1973cited by this paper
• Letter: Growth of pulmonary alveolar macrophages in vitro.

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments

  1973cited by this paper
• Growth of Pulmonary Alveolar Macrophages in vitro

  1973cited by this paper
• Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.

  1972cited by this paper
• Altered response to apomorphine in 6-hydroxydopamine-treated rats.

  1972cited by this paper
• Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• The occurrence, distribution and physiological role of catecholamines in the nervous system.

  1959cited by this paper

• Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration

  2025cites this paper
• Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression

  2025influential citation
• Susceptibility and diffusion MRI biomarkers predict development of Parkinsonism in iRBD

  2025cites this paper
• Resilience of striatal synaptic plasticity over early structural adaptations in premotor parkinsonism

  2025cites this paper
• Rethinking Parkinson's disease: could dopamine reduction therapy have clinical utility?

  2024cites this paper
• Phosphodiesterase inhibition and Gucy2C activation enhance tyrosine hydroxylase Ser40 phosphorylation and improve 6-hydroxydopamine-induced motor deficits

  2024cites this paper
• Serotonin as a biomarker of toxin-induced Parkinsonism

  2024cites this paper
• Desiderata for Normative Models of Synaptic Plasticity

  2024cites this paper
• The basal forebrain cholinergic system as target for cell replacement therapy in Parkinson’s disease

  2024cites this paper
• The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models

  2024cites this paper
• The hormesis principle of neuroplasticity and neuroprotection.

  2024cites this paper
• Using Microdialysis to Monitor Dopaminergic Support of Limb-Use Control Following Mesencephalic Neurosphere Transplantation in a Rodent Model of Parkinson's Disease.

  2024cites this paper
• Dynamical questions in volume transmission

  2023cites this paper
• Locus coeruleus tyrosine hydroxylase positive neurons mediated the peripheral and central therapeutic effects of transcutaneous auricular vagal nerve stimulation (taVNS) in MRL/lpr mice.

  2023cites this paper
• Desiderata for normative models of synaptic plasticity

  2023cites this paper
• The genesis and functional consequences of cortico-subthalamic beta augmentation and excessive subthalamic burst discharges after dopaminergic deprivation.

  2022cites this paper
• Biophysical Modeling of Dopaminergic Denervation Landscapes in the Striatum Reveals New Therapeutic Strategy

  2022cites this paper
• MPTP induces neurodegeneration by modulating dopaminergic activity in catfish brain.

  2022cites this paper
• Enhancing the resolution of behavioral measures: Key observations during a forty year career in behavioral neuroscience.

  2022cites this paper
• Local striatal volume and motor reserve in drug-naïve Parkinson’s disease

  2022cites this paper
• Depotentiation of associative plasticity is intact in Parkinson's disease with mild dyskinesia.

  2022cites this paper
• Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism

  2022cites this paper
• Recurrent Neural Circuits Overcome Partial Inactivation by Compensation and Re-learning

  2021cites this paper
• Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1

  2021cites this paper
• Simultaneous Measurement of Striatal Dopamine and Hydrogen Peroxide Transients Associated with L-DOPA Induced Rotation in Hemiparkinsonian Rats

  2021cites this paper
• Elevated Dopamine Synthesis as a Mechanism of Cognitive Resilience in Aging.

  2021cites this paper
• Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain

  2020cites this paper
• Nonlinear pharmacodynamics of levodopa through Parkinson's disease progression.

  2020cites this paper
• An integrative model of Parkinson’s disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progression

  2020cites this paper
• A role for α-Synuclein in axon growth and its implications in corticostriatal glutamatergic plasticity in Parkinson’s disease

  2020cites this paper
• An integrative model of Parkinson’s disease treatment including levodopa pharmacokinetics, dopamine kinetics, basal ganglia neurotransmission and motor action throughout disease progression

  2020cites this paper
• Theoretical analysis predicts an optimal therapeutic strategy in distinct parkinsonian landscapes of the striatum

  2020cites this paper
• Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease

  2019cites this paper
• Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.

  2019cites this paper
• AAV2/DJ-mediated alpha-synuclein overexpression in the rat substantia nigra as early stage model of Parkinson’s disease

  2019cites this paper
• State transitions in the substantia nigra reticulata predict the onset of motor deficits in models of progressive dopamine depletion in mice

  2019cites this paper
• Molecular Imaging of the Dopamine Transporter

  2019cites this paper
• The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention.

  2019cites this paper
• Classic animal models of Parkinson's disease: a historical perspective.

  2019cites this paper
• The Locus coeruleus in Parkinson’s disease - from basic research to new translational perspectives -

  2019cites this paper
• Leak ADAPTATION AND SENSITIZATION TO PROTEOTOXIC STRESS

  2019cites this paper
• Characterization of striatum-mediated behavior and neurochemistry in the DJ-1 knock-out rat model of Parkinson's disease.

  2019cites this paper
• Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.

  2019cites this paper
• Selective Regulation of 5-HT1B Serotonin Receptor Expression in the Striatum by Dopamine Depletion and Repeated L-DOPA Treatment: Relationship to L-DOPA-Induced Dyskinesias

  2019cites this paper
• Behavioral tests predicting striatal dopamine level in a rat hemi‐Parkinson's disease model

  2019cites this paper
• Late onset depression: Association with clinical and imaging indicators of prodromal Parkinson’s disease

  2019cites this paper
• Sleep deprivation disrupts striatal anti-apoptotic responses in 6-hydroxy dopamine-lesioned parkinsonian rats

  2018cites this paper
• Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques.

  2018cites this paper
• Evidence for cross-hemispheric preconditioning in experimental Parkinson’s disease

  2018cites this paper
• Enhancing and Extending Biological Performance and Resilience

  2018cites this paper
• Simulated viral infection in early-life alters brain morphology, activity and behavior in zebra finches (Taeniopygia guttata).

  2018cites this paper
• Conditioning Against the Pathology of Parkinson's disease.

  2018influential citation
• Sensor Array for Detection of Early Stage Parkinson's Disease before Medication.

  2018cites this paper
• Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson’s disease

  2018cites this paper
• Substantia nigra dopaminergic neurons and striatal interneurons are engaged in three parallel but interdependent postnatal neurotrophic circuits

  2018cites this paper
• 11 Normal and Physio-Pathological Striatal Dopamine Homeostasis

  2017cites this paper
• Expanding the repertoire of L-DOPA's actions: A comprehensive review of its functional neurochemistry.

  2017cites this paper
• Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease

  2017cites this paper
• Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model

  2017cites this paper
• Reduced ability of calcitriol to promote augmented dopamine release in the lesioned striatum of aged rats

  2017cites this paper
• Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification.

  2017cites this paper
• Partial Lesion of the Nigrostriatal Dopamine Pathway in Rats Impairs Egocentric Learning but Not Spatial Learning or Behavioral Flexibility

  2017cites this paper
• Changes in SK channel expression in the basal ganglia after partial nigrostriatal dopamine lesions in rats: Functional consequences

  2017cites this paper
• Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia : The Findings , the Debate , and the Therapeutic Implications

  2017cites this paper
• Mathematical Models of Neuromodulation and Implications for Neurology and Psychiatry

  2017cites this paper
• Mechanistic insights into neuronal oscillatory activity in the dopamine-intact and dopamine-depleted primary motor cortex

  2017cites this paper
• Motor dysfunction and alterations in glutathione concentration, cholinesterase activity, and BDNF expression in substantia nigra pars compacta in rats with pedunculopontine lesion.

  2017cites this paper
• Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA

  2017cites this paper
• Pilot study: molecular risk factors for diagnosing sporadic Parkinson's disease based on gene expression in blood in MPTP-induced rhesus monkeys

  2017cites this paper
• Altered Volatile Organic Compound Profile in Transgenic Rats Bearing A53T Mutation of Human α-Synuclein: Comparison with Dopaminergic and Serotonergic Denervation.

  2017cites this paper
• Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease

  2017cites this paper
• Role of the Axon Initial Segment in the Control of Spontaneous Frequency of Nigral Dopaminergic Neurons In Vivo

  2017cites this paper
• The Impact of Short and Long-Term Exercise on the Expression of Arc and AMPARs During Evolution of the 6-Hydroxy-Dopamine Animal Model of Parkinson’s Disease

  2017cites this paper
• Consideration of Biological Sex in Translating Regenerative Stem Cell Therapies

  2017cites this paper
• Effects of an Early Life Immune Challenge on Body Growth, Personality, Mating Behaviors, and Brain Development of Zebra Finches (Taeniopygia guttata)

  2017cites this paper
• Neuronal replacement therapy: previous achievements and challenges ahead

  2017cites this paper
• Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus

  2017cites this paper
• The effect of L-dopa and neuroprotective agents on cell replacement therapy for Parkinson's disease

  2017cites this paper
• Proximity of Substantia Nigra Microstimulation to Putative GABAergic Neurons Predicts Modulation of Human Reinforcement Learning

  2017cites this paper
• Parkinson’s Disease and the Cerebral Cortex

  2017cites this paper
• Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson’s disease using [11C]PBR28 and [18F]FDOPA PET

  2017cites this paper
• The cannabinoid type-2 (CB2) receptor as a target for anti-inflammatory disease modification in Parkinson's disease

  2016cites this paper
• Exogenous α-Synuclein Monomers Alter Dopamine Metabolism in Murine Brain

  2016cites this paper
• Differential pattern of motor impairments in neurotoxic, environmental and inflammation-driven rat models of Parkinson's disease.

  2016cites this paper
• Is Alpha-Synuclein Loss-of-Function a Contributor to Parkinsonian Pathology? Evidence from Non-human Primates

  2016cites this paper
• 2015 Distinguished career award: Reflections on a career in science.

  2016cites this paper
• Adaptations in in vivo catecholamine signaling in models of stress and addiction

  2016cites this paper
• The astrocytic response to the dopaminergic denervation of the striatum

  2016cites this paper
• Neuroimaging studies of brain networks in Parkinson's disease

  2016cites this paper
• Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications

  2016cites this paper
• Medullary Norepinephrine Projections Release Norepinephrine into the Contralateral Bed Nucleus of the Stria Terminalis

  2016cites this paper
• Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia : The Findings , the Debate , and the Therapeutic Implications

  2016cites this paper
• Neural repair in the adult brain

  2016cites this paper
• Microstimulation near fast-spiking human substantia nigra neurons impairs reinforcement learning

  2016cites this paper
• The astrocyte role in the dying-back degeneration of DAns

  2016cites this paper
• Initial treatment of Parkinson's disease in 2016: The 2000 consensus conference revisited.

  2016cites this paper
• Cross-hemispheric dopamine projections have functional significance

  2016cites this paper
• Understanding the regulation of adult-neurogenesis following acute and neurodegenerative brain injury

  2016cites this paper
• Ceftriaxone prevents and reverses behavioral and neuronal deficits in an MPTP-induced animal model of Parkinson's disease dementia.

  2015cites this paper
• Increased latencies to initiate cocaine self-administration following laterodorsal tegmental nucleus lesions.

  2015cites this paper